Project Details
SFB 665: Developmental Disturbances in the Nervous System
Subject Area
Medicine
Term
from 2005 to 2017
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 12959370
Advances in genetics and molecular biology in the past two decades have made it possible to analyse the molecules that control nervous system development and to identify genetic alterations that result in a disturbance of this process. However, the mechanisms and molecules that establish and maintain neuronal circuits are still not completely understood.
For basic and clinical neuroscientists, the present challenge can be framed by the following questions: How can we best integrate genetic, cellular and biochemical data to understand genes and their functions on a mechanistic level? How can the understanding of developmental disturbances in patients benefit from the knowledge of molecular mechanisms gained from animal models? How can the knowledge of phenotypes observed in humans, where higher order complexity can be addressed, inform the analysis of gene function in animals?We take up this challenge by joining the efforts of investigators who use genetic analyses in animal models to study nervous system development, researchers who assess nervous system functions on a cellular, biochemical or physiological level, and clinicians who identify the genetic causes of developmental disturbances in their patients.
Our initiative is organised along two fundamental themes in contemporary developmental neuroscience, the mechanisms underlying pattern formation and cell specification (in project area A), and neural connectivity and signalling (in project area B). To bundle these lines of research will, in the short term, allow the members of the Collaborative Research Centre to benefit from the know-how and technologies of the other disciplines in their analysis of gene functions. In the long term, we hope to achieve a better understanding of the causal relationship between mutation and neurological phenotypes, thereby providing a basis for future improvements in therapeutic strategies.
The proposed projects are united by a basic interest in normal and altered mechanisms of nervous system development. Their common aim is to further knowledge of biological systems that will, in the long term, contribute to the understanding of human disease. We have included several projects jointly headed by a basic and a clinical researcher. In this way, we follow the concept of Clinical Research provided by the German Research Foundation (DFG-Denkschrift Klinische Forschung , 1999), which explicitly acknowledges the combination of basic science, disease-oriented science, and patient-oriented science.
For basic and clinical neuroscientists, the present challenge can be framed by the following questions: How can we best integrate genetic, cellular and biochemical data to understand genes and their functions on a mechanistic level? How can the understanding of developmental disturbances in patients benefit from the knowledge of molecular mechanisms gained from animal models? How can the knowledge of phenotypes observed in humans, where higher order complexity can be addressed, inform the analysis of gene function in animals?We take up this challenge by joining the efforts of investigators who use genetic analyses in animal models to study nervous system development, researchers who assess nervous system functions on a cellular, biochemical or physiological level, and clinicians who identify the genetic causes of developmental disturbances in their patients.
Our initiative is organised along two fundamental themes in contemporary developmental neuroscience, the mechanisms underlying pattern formation and cell specification (in project area A), and neural connectivity and signalling (in project area B). To bundle these lines of research will, in the short term, allow the members of the Collaborative Research Centre to benefit from the know-how and technologies of the other disciplines in their analysis of gene functions. In the long term, we hope to achieve a better understanding of the causal relationship between mutation and neurological phenotypes, thereby providing a basis for future improvements in therapeutic strategies.
The proposed projects are united by a basic interest in normal and altered mechanisms of nervous system development. Their common aim is to further knowledge of biological systems that will, in the long term, contribute to the understanding of human disease. We have included several projects jointly headed by a basic and a clinical researcher. In this way, we follow the concept of Clinical Research provided by the German Research Foundation (DFG-Denkschrift Klinische Forschung , 1999), which explicitly acknowledges the combination of basic science, disease-oriented science, and patient-oriented science.
DFG Programme
Collaborative Research Centres
Completed projects
- A01 - Molecular control of the development and function of primary and secondary sensory neurons (Project Head Birchmeier, Carmen )
- A02 - miRNAs and their mRNA targets in neural stem cells (Project Head Wulczyn, F. Gregory )
- A03 - The ontogeny, phylogeny and pathology of NKX2.1 gene function in the brain (Project Head Krude, Heiko )
- A04 - The role von FoxP2 for the development and function of neural circuits mediating vocal production learning (Project Head Scharff, Ph.D., Constance )
- A05 - Sonic hedgehog regulation during development and in disorders of the nervous system (Project Heads Mundlos, Stefan ; Schwabe, Georg C. )
- A06 - Dysfunction of mitochondrial complex I as a cause of impaired brain development in Leigh syndrome (Project Heads Kann, Oliver ; Schülke-Gerstenfeld, Markus )
- A07 - Neuronal T3 transport and interneuron development (Project Heads Grüters-Kieslich, Annette ; Krude, Heiko ; Schweizer, Ulrich )
- A08 - Molecular pathways in forebrain development and holoprosencephaly (Project Heads Hammes-Lewin, Annette E. ; Willnow, Thomas E. )
- A09 - CDK5RAP2 and novel microephaly genes in brain development (Project Heads Kaindl, Angela ; Tarabykin, Victor )
- A10 - Molecular control of production and specification of cortical upper layer neurons (Project Head Tarabykin, Victor )
- A11 - Analyses of the function and regulation of the PTEN suppressor during early brain development (Project Head Eickholt, Britta )
- B01 - Nrg1 and ErbB receptors in Schwann cell development and myelination (Project Heads Birchmeier, Carmen ; Garratt, Alistair ; Müller, Thomas ; Wende, Hagen )
- B02 - A cGMP signaling cascade controlling axonal branching and neuronal circuitry (Project Heads Rathjen, Fritz G. ; Schmidt, Hannes )
- B03 - PRG-1:Molecular mechanisms and role in juvenile epilepsy (Project Head Nitsch, Robert )
- B05 - Application of new genetic approaches to the study of ion channels and molecular components in the development of the auditory nervous system (Project Head Ibanez-Tallon, Ines )
- B06 - Common genes required for normal mechanotransduction in touch and hearing (Project Heads Gross, Manfred ; Lewin, Ph.D., Gary Richard )
- B07 - The Role of Gap Junction Protein alpha 12 (Connexin 46.6) in CNS Myelination (Project Heads Hübner, Christoph ; Kettenmann, Helmut ; Uhlenberg, Birgit )
- B08 - Induction and suppression of febrile seizures (Project Heads Schmitz, Dietmar ; Schuchmann, Sebastian )
- B09 - Active Zone Protein Transport and Autism (Project Head Sigrist, Stephan J. )
- B10 - Experience-dependent development of the cortical representation of social touch (Project Head Brecht, Michael )
- B11 - Role of excitation-inhibition in Rett syndrome (Project Head Rosenmund, Christian )
- B12 - Auditory processing deficits in autism: auditory brainstem disturbances and the role of neuroligin-3 (Project Head Koch, Ursula )
- B13 - Unterstanding the function of Shank2 and its role in autism (Project Head Schmitz, Dietmar )
- B14 - Synaptic Mechanisms underlying Phelan McDermid and Asperger's Syndrome (Project Head Garner, Craig C. )
- C01 - Transgenic Core Facility (Project Heads Birchmeier, Carmen ; Jerchow, Boris ; Michel, Geert ; Tarabykin, Victor ; Wende, Hagen )
- C03 - Administrative office of the SFB (Project Head Rosenmund, Christian )
- C04 - Clinical and Genetic Assessment Unit (Project Heads Mundlos, Stefan ; Schülke-Gerstenfeld, Markus )
Applicant Institution
shared FU Berlin and HU Berlin through:
Charité - Universitätsmedizin Berlin
Charité - Universitätsmedizin Berlin
Co-Applicant Institution
Freie Universität Berlin; Humboldt-Universität zu Berlin
Participating Institution
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Spokesperson
Professor Dr. Christian Rosenmund